Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 325

1.

Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006.

Dickinson JA, Stankiewicz A, Popadiuk C, Pogany L, Onysko J, Miller AB.

BMC Public Health. 2012 Nov 16;12:992. doi: 10.1186/1471-2458-12-992.

2.

Cervical cancer screening in the United States and the Netherlands: a tale of two countries.

Habbema D, De Kok IM, Brown ML.

Milbank Q. 2012 Mar;90(1):5-37. doi: 10.1111/j.1468-0009.2011.00652.x.

3.

Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991.

Levi F, La Vecchia C, Randimbison L, Te VC.

Ann Oncol. 1994 Oct;5(8):747-52.

PMID:
7826908
4.
5.

Factors associated with cervical cancer screening uptake among Inuit women in Nunavik, Quebec, Canada.

Cerigo H, Coutlée F, Franco EL, Brassard P.

BMC Public Health. 2013 May 3;13:438. doi: 10.1186/1471-2458-13-438.

7.

Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.

Vutuc C, Haidinger G, Waldhoer T, Ahmad F, Breitenecker G.

Wien Klin Wochenschr. 1999 May 7;111(9):354-9.

PMID:
10407996
8.

Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994).

Walker JJ, Brewster D, Gould A, Raab GM.

Public Health. 1998 Nov;112(6):373-8.

PMID:
9883033
9.

Cervical cancer in Canada: changing patterns in incidence and mortality.

Liu S, Semenciw R, Probert A, Mao Y.

Int J Gynecol Cancer. 2001 Jan-Feb;11(1):24-31.

PMID:
11285030
10.

Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.

Sriplung H, Singkham P, Iamsirithaworn S, Jiraphongsa C, Bilheem S.

Asian Pac J Cancer Prev. 2014;15(22):10003-8.

11.

Evaluation of the National Cervical Cancer Screening Programme in Singapore.

Jin AZ, Louange EC, Chow KY, Fock CW.

Singapore Med J. 2013 Feb;54(2):96-101.

12.

Trends in cervical cancer mortality in the Americas.

Robles SC, White F, Peruga A.

Bull Pan Am Health Organ. 1996 Dec;30(4):290-301.

PMID:
9041740
13.
14.
15.

An evaluation of the National Cervical Screening Programme Otago site.

Coppell K, Paul C, Cox B.

N Z Med J. 2000 Feb 25;113(1104):48-51.

PMID:
10777223
16.

Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.

Deerasamee S, Srivatanakul P, Sriplung H, Nilvachararung S, Tansuwan U, Pitakpraiwan P, Kaewkungwal J, Singhasivanon P, Nimnakorn P, Sankaranarayanan R.

Asian Pac J Cancer Prev. 2007 Oct-Dec;8(4):547-56.

17.

Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.

Swaddiwudhipong W, Chaovakiratipong C, Nguntra P, Mahasakpan P, Lerdlukanavonge P, Koonchote S.

Int J Epidemiol. 1995 Jun;24(3):493-8.

PMID:
7672887
18.
19.

Trends in breast cancer by race and ethnicity: update 2006.

Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M.

CA Cancer J Clin. 2006 May-Jun;56(3):168-83.

20.

Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.

Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.

J Natl Cancer Inst. 2002 Oct 2;94(19):1469-83.

Items per page

Supplemental Content

Write to the Help Desk